Shubham Swasti, Ahuja Arvind, Bhardwaj Minakshi
Department of Pathology, ICMR-National Institute for Research in Environmental Health, Bhopal, Madhya Pradesh, India.
Department of Pathology, PGIMER and Dr. RML Hospital, New Delhi, India.
J Lab Physicians. 2019 Oct-Dec;11(4):330-334. doi: 10.4103/JLP.JLP_106_19.
Phyllodes tumors (PTs) are the fibroepithelial neoplasms of the breast. Histologically, PTs are divided into three subgroups according to their clinicopathological behavior: benign, borderline, and malignant. It is at times difficult to ascertain the grade of PT on morphological criteria alone, especially borderline PT may be at times difficult to distinguish from its benign or malignant counterparts.
This study was undertaken to evaluate an immunohistochemical panel of Ki-67, p53, and CD10 in PT and to determine their expression in PT in correlation with its grade.
This was a retrospective study.
The study included six malignant, six borderline, and twelve benign PT. Expressions of Ki-67, p53, and CD10 were evaluated on all the 12 cases and compared in these three categories.
Chi-square test was applied, and < 0.05 was taken as statistically significant.
Stromal expression of Ki-67 and p53 between the benign and borderline/malignant group showed a statistically significant difference. Neither CD10 expression nor epithelial expressions of Ki-67 and p53 were found significant. Periepithelial accentuation of Ki-67 and p53 immunostaining was noted in all positive cases.
Ki-67 labeling index and p53 immunostaining can be a useful adjunct to determine the grade in difficult cases. However, no single immunomarker can reliably distinguish between benign and borderline phyllodes in all cases.
叶状肿瘤(PTs)是乳腺的纤维上皮性肿瘤。在组织学上,PTs根据其临床病理行为分为三个亚组:良性、交界性和恶性。有时仅根据形态学标准很难确定PT的分级,尤其是交界性PT有时可能难以与其良性或恶性对应物区分开来。
本研究旨在评估Ki-67、p53和CD10在PT中的免疫组织化学检测组合,并确定它们在PT中的表达与其分级的相关性。
这是一项回顾性研究。
该研究包括6例恶性、6例交界性和12例良性PT。对所有12例病例评估Ki-67、p53和CD10的表达,并在这三个类别中进行比较。
应用卡方检验,P<0.05被视为具有统计学意义。
良性组与交界性/恶性组之间Ki-67和p53的基质表达存在统计学显著差异。未发现CD10表达以及Ki-67和p53的上皮表达具有显著性。在所有阳性病例中均观察到Ki-67和p53免疫染色的上皮周围增强。
Ki-67标记指数和p53免疫染色可作为确定疑难病例分级的有用辅助手段。然而,没有单一的免疫标志物能在所有病例中可靠地区分良性和交界性叶状肿瘤。